PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Sep-2024 Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 AccessWire
09-Sep-2024 CELLTech(TM) DBS: Your Brain’s Healing Power Under Your Control AccessWire
09-Sep-2024 iCardio.ai and SARC MedIQ PACS Partner to Revolutionize Ultrasound Interpretation With AI Tools AccessWire
09-Sep-2024 Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation Pierre Fabre Laboratories
09-Sep-2024 Deafblind UK is proud to announce its highly anticipated 2024 conference, ‘Standing Out and Fitting In’, set to take place online on the 3 October 2024. Deafblind UK
09-Sep-2024 AstraZeneca announces the completion of the clinical programme to support the transition of Breztri to next-generation propellant with near-zero Global Warming Potential AstraZeneca
09-Sep-2024 The OTL Group toasts 40 years of success OTL Group
09-Sep-2024 TILT Biotherapeutics Presents Clinical Data on TILT-123 After Fully Intravenous Delivery Regimen at ESMO 2024 TILT Biotherapeutics
09-Sep-2024 Anocca Presents Data at ESMO Congress on Preclinical Development of its TCR-T Cell Therapies for Cancer Anocca
09-Sep-2024 HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer HUTCHMED
09-Sep-2024 Transgene and BioInvent to Present Promising Initial Phase I/IIa Data on Oncolytic Virus, BT-001, at ESMO 2024 Transgene and BioInvent
09-Sep-2024 SMC accepts bispecific antibody TECVAYLI®▼ (teclistamab) for eligible patients with relapsed and refractory multiple myeloma Johnson & Johnson
09-Sep-2024 Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement AccessWire
09-Sep-2024 Ankle & Foot Centers of America Gets Athletes Back on the Field AccessWire
09-Sep-2024 Medholdings Group Inc. Acquires MedSmart Wellness Centers AccessWire
09-Sep-2024 The Center for Immunology Science and Immunology Diagnostics Announce a Major Breakthrough Discovery: DNA-Based Proof of the Disease of Fibromyalgia Newswire
09-Sep-2024 Secarna Pharmaceuticals will present data at 6th Inflammasome Therapeutics Summit demonstrating the potential of ASOs to target the expression of NLRP3 Secarna Pharmaceuticals GmbH & Co. KG
09-Sep-2024 Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024 AccessWire
09-Sep-2024 The Center for Immunology Science and Immunology Diagnostics Announce a Major Breakthrough Discovery: DNA-Based Proof of the Disease of Fibromyalgia AccessWire
09-Sep-2024 Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis AccessWire